English
Home > Products > 32955-21-8

China 32955-21-8 Factory

Getting buyer gratification is our company's purpose endlessly. We will make good attempts to produce new and top-quality products, meet up with your specific requirements and provide you with pre-sale, on-sale and after-sale expert services for 32955-21-8,CAS NO 32955-21-8,Dasatinib intermediate,Dasatinib advance intermediate,Ethyl 2-aminothiazole, In case you have any comments about our corporation or products, you should experience no cost to call us, your coming mail will be remarkably appreciated.
32955-21-8, We welcome you to visit our company and factory. It is also convenient to visit our website. Our sales team will present you the best service. If you have to have more information, remember to feel free to contact us by E-mail or telephone. We have been sincerely hope to establish a good long-term business relationship with you through this opportunity, based on equal, mutual benefit from now till the future.

Related Products

Hot Products

  • 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone

    1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone

    Product Name:1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone
    Molecular Formula:C12H16O5S
    Molecular Weight:272.32
    CAS Registry Number:1450657-28-9
  • Actinomycin D

    Actinomycin D

    Product Name:Actinomycin D
    Molecular Formula:C62H86N12O16
    Molecular Weight;1255.42
    CAS Registry Number;50-76-0
  • Benzene, 1,2,3-trifluoro-4-methoxy- (9CI)

    Benzene, 1,2,3-trifluoro-4-methoxy- (9CI)

    Product Name:Benzene, 1,2,3-trifluoro-4-methoxy- (9CI)
    Molecular Formula:C7H5F3O
    Molecular Weight:162.11
    CAS Registry Number:203245-16-3
  • LeterMovir

    LeterMovir

    Product Name:LeterMovir
    Molecular Formula:C29H28F4N4O4
    Molecular Weight;572.55
    CAS Registry Number;917389-32-3
  • DM4

    DM4

    Product Name:DM4
    Molecular Formula:C38H54ClN3O10S
    Molecular Weight:780.37
    CAS Registry Number:796073-69-3
  • (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    Product Name:(3-Chloropyrazin-2-yl)MethanaMine hydrochloride
    Molecular Formula:C5H7Cl2N3
    Molecular Weight:180.03
    CAS Registry Number:939412-86-9
  • Related Blog
  • Reviews

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 32955-21-8

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept